| Values |
---|---|
Subject number | 327 |
Age | 44.21 ± 11.22 |
Gender | |
  Male | 280 (85.63%) |
  Female | 47 (14.37%) |
Liver Histology | |
 ISHAK Fibrosis Stages | |
  0 | 2 (0.61%) |
  1 | 40 (12.23%) |
  2 | 51 (15.60%) |
  3 | 110 (33.64%) |
  4 | 33 (10.09%) |
  5 | 74 (22.63%) |
  6 | 17 (5.20%) |
 Piecemeal necrosis | |
  0 | 101 (30.89%) |
  1 | 165 (50.46%) |
  2 | 47 (14.37%) |
  3 | 14 (4.28%) |
 Confluent necrosis | |
  0 | 307 (93.88%) |
  1 | 6 (1.83%) |
  2 | 2 (0.61%) |
  3 | 1 (0.31%) |
  4 | 10 (3.06%) |
  5 | 1 (0.31%) |
 Focal (spotty) lytic necrosis, apoptosis and focal inflammation | |
  0 | 2 (0.61%) |
  1 | 93 (28.44%) |
  2 | 161 (49.24%) |
  3 | 67 (20.49%) |
  4 | 4 (1.22%) |
 Portal inflammation | |
  0 | 6 (1.83%) |
  1 | 77 (23.55%) |
  2 | 103 (31.50%) |
  3 | 123 (37.61%) |
  4 | 17 (5.20%) |
  5 | 1 (0.31%) |
 Viral serology | |
  HBV DNA (log10 IU/ml) | 6.35 ± 1.71 |
  HBeAg positive | 146 (44.65%) |
  HBsAg (log10 IU/ml) | 3.33 ± 0.98 |
 Hematology | |
  ALT (IU/L) | 177.31 ± 173.34 |
  AST (IU/L) | 106.96 ± 122.57 |
  Bilirubin (mg/dL) | 0.98 ± 0.42 |
  Albumin (g/dL) | 4.55 ± 0.35 |
  Gamma-glutamyltransferase (IU/L) | 59.53 ± 46.75 |
  Platelet (1000/mm3) | 189.78 ± 50.31 |
  Hemoglobin (g/dL) | 15.20 ± 1.36 |